Patent · US Active

Glucocorticoid receptor modulators to treat cervical cancer

US10413540B2 · kind B2 · utility

15Cited by
19References
10Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 30, 2018
Grant dateSep 17, 2019
Priority date—
Expiry dateMar 30, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating a subject having a cancerous tumor are disclosed. The methods comprise administering to the subject an effective amount of a non-steroidal selective glucocorticoid receptor modulator (SGRM) and an effective amount of a chemotherapeutic agent. The tumor may be cervical cancer. The SGRM may be a fused azadecalin. In embodiments, the SGRM may be a heteroaryl ketone fused azadecalin or an octahydro fused azadecalin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.